Clinical significance of ADAMTS-13/vWF axis in pregnant women at different trimesters of gestation

Introduction. The pandemic of a novel coronavirus infection has demonstrated the importance of assessing the ADAMTS-13/vWF axis in patients with COVID-19, because a decline in this ratio mirrors disease severity. However very few data in the global literature on crosstalk and ADAMTS-13/vWF levels in...

Full description

Saved in:
Bibliographic Details
Published in:Акушерство, гинекология и репродукция Vol. 17; no. 2; pp. 221 - 230
Main Authors: Grigoreva, K. N., Gashimova, N. R., Bitsadze, V. O., Pankratyeva, L. L., Khizroeva, J. Kh, Tretyakova, M. V., Tsibizova, V. I., Degtyareva, N. D., Mulenkova, A. V., Gris, J.-C., Kvaratskheliia, M. V., Grandone, E., Yakubova, F. E., Blinov, D. V., Makatsariya, A. D.
Format: Journal Article
Language:English
Published: IRBIS LLC 22-05-2023
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Introduction. The pandemic of a novel coronavirus infection has demonstrated the importance of assessing the ADAMTS-13/vWF axis in patients with COVID-19, because a decline in this ratio mirrors disease severity. However very few data in the global literature on crosstalk and ADAMTS-13/vWF levels in pregnant women remaining very contradictory are available. Taking into consideration an impact of the ADAMTS-13/vWF axis on prevalence of thrombosis and disorders in the hemostasis system, investigation of this issue is highly demanded. Aim: to assess the functioning of the ADAMTS-13/vWF axis during physiological pregnancy. Materials and Methods . A controlled non-randomized study was conducted: main group included 44 women with physiologically occurring pregnancies at I, II and III trimesters; the control group consisted of 45 healthy non-pregnant women. The plasma level of ADAMTS-13 inhibitor (ADAMTS-13:i), ADAMTS-13 antigen (ADAMTS-13:Ag), vWF antigen (vWF:Ag), and ADAMTS-13 activity (ADAMTS-13:Ac) as well as relevant ratio (ADAMTS-13:Ac/vWF:Ag) were measured. Results. It was shown that in parallel with increasing gestational age, significant changes occurred in the ADAMTS-13:Ac/vWF:Ag ratio. In main group, patients at II trimester were found to have level of ADAMTS-13:Ac/vWF:Ag 0.359 ± 0.121, in III trimester –0.253 ± 0.741, which significantly differed (p < 0.01) compared to control group with non-pregnant women (1,134 ± 0,308). Conclusion . Our study provides new insights into the functioning of the ADAMTS-13:/vWF axis in women with physiologically occurring pregnancy at I, II and III trimesters. Decline in ADAMTS-13:Ac was demonstrated along with increasing vWF:Ag level observed in parallel with increasing gestational age. Apparently, the progressive decrease of ADAMTS-13 concentration during pregnancy is associated with its increased consumption due to high vWF level. However, due to the small single-center patient cohort, further studies with larger-scale studies are needed.
AbstractList Introduction. The pandemic of a novel coronavirus infection has demonstrated the importance of assessing the ADAMTS-13/vWF axis in patients with COVID-19, because a decline in this ratio mirrors disease severity. However very few data in the global literature on crosstalk and ADAMTS-13/vWF levels in pregnant women remaining very contradictory are available. Taking into consideration an impact of the ADAMTS-13/vWF axis on prevalence of thrombosis and disorders in the hemostasis system, investigation of this issue is highly demanded.Aim: to assess the functioning of the ADAMTS-13/vWF axis during physiological pregnancy.Materials and Methods. A controlled non-randomized study was conducted: main group included 44 women with physiologically occurring pregnancies at I, II and III trimesters; the control group consisted of 45 healthy non-pregnant women. The plasma level of ADAMTS-13 inhibitor (ADAMTS-13:i), ADAMTS-13 antigen (ADAMTS-13:Ag), vWF antigen (vWF:Ag), and ADAMTS-13 activity (ADAMTS-13:Ac) as well as relevant ratio (ADAMTS-13:Ac/vWF:Ag) were measured.Results. It was shown that in parallel with increasing gestational age, significant changes occurred in the ADAMTS-13:Ac/vWF:Ag ratio. In main group, patients at II trimester were found to have level of ADAMTS-13:Ac/vWF:Ag 0.359 ± 0.121, in III trimester –0.253 ± 0.741, which significantly differed (p < 0.01) compared to control group with non-pregnant women (1,134 ± 0,308).Conclusion. Our study provides new insights into the functioning of the ADAMTS-13:/vWF axis in women with physiologically occurring pregnancy at I, II and III trimesters. Decline in ADAMTS-13:Ac was demonstrated along with increasing vWF:Ag level observed in parallel with increasing gestational age. Apparently, the progressive decrease of ADAMTS-13 concentration during pregnancy is associated with its increased consumption due to high vWF level. However, due to the small single-center patient cohort, further studies with larger-scale studies are needed.
Introduction. The pandemic of a novel coronavirus infection has demonstrated the importance of assessing the ADAMTS-13/vWF axis in patients with COVID-19, because a decline in this ratio mirrors disease severity. However very few data in the global literature on crosstalk and ADAMTS-13/vWF levels in pregnant women remaining very contradictory are available. Taking into consideration an impact of the ADAMTS-13/vWF axis on prevalence of thrombosis and disorders in the hemostasis system, investigation of this issue is highly demanded. Aim: to assess the functioning of the ADAMTS-13/vWF axis during physiological pregnancy. Materials and Methods . A controlled non-randomized study was conducted: main group included 44 women with physiologically occurring pregnancies at I, II and III trimesters; the control group consisted of 45 healthy non-pregnant women. The plasma level of ADAMTS-13 inhibitor (ADAMTS-13:i), ADAMTS-13 antigen (ADAMTS-13:Ag), vWF antigen (vWF:Ag), and ADAMTS-13 activity (ADAMTS-13:Ac) as well as relevant ratio (ADAMTS-13:Ac/vWF:Ag) were measured. Results. It was shown that in parallel with increasing gestational age, significant changes occurred in the ADAMTS-13:Ac/vWF:Ag ratio. In main group, patients at II trimester were found to have level of ADAMTS-13:Ac/vWF:Ag 0.359 ± 0.121, in III trimester –0.253 ± 0.741, which significantly differed (p < 0.01) compared to control group with non-pregnant women (1,134 ± 0,308). Conclusion . Our study provides new insights into the functioning of the ADAMTS-13:/vWF axis in women with physiologically occurring pregnancy at I, II and III trimesters. Decline in ADAMTS-13:Ac was demonstrated along with increasing vWF:Ag level observed in parallel with increasing gestational age. Apparently, the progressive decrease of ADAMTS-13 concentration during pregnancy is associated with its increased consumption due to high vWF level. However, due to the small single-center patient cohort, further studies with larger-scale studies are needed.
Author Bitsadze, V. O.
Pankratyeva, L. L.
Yakubova, F. E.
Blinov, D. V.
Grandone, E.
Degtyareva, N. D.
Makatsariya, A. D.
Tsibizova, V. I.
Grigoreva, K. N.
Tretyakova, M. V.
Gashimova, N. R.
Khizroeva, J. Kh
Mulenkova, A. V.
Gris, J.-C.
Kvaratskheliia, M. V.
Author_xml – sequence: 1
  givenname: K. N.
  orcidid: 0000-0002-7756-8935
  surname: Grigoreva
  fullname: Grigoreva, K. N.
  organization: Sechenov University
– sequence: 2
  givenname: N. R.
  orcidid: 0000-0003-0764-4477
  surname: Gashimova
  fullname: Gashimova, N. R.
  organization: Sechenov University
– sequence: 3
  givenname: V. O.
  orcidid: 0000-0001-8404-1042
  surname: Bitsadze
  fullname: Bitsadze, V. O.
  organization: Sechenov University
– sequence: 4
  givenname: L. L.
  orcidid: 0000-0002-1339-4155
  surname: Pankratyeva
  fullname: Pankratyeva, L. L.
  organization: Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Health Ministry of Russian Federation; Vorokhobov City Clinical Hospital No 67, Moscow Healthcare Department
– sequence: 5
  givenname: J. Kh
  orcidid: 0000-0002-0725-9686
  surname: Khizroeva
  fullname: Khizroeva, J. Kh
  organization: Sechenov University
– sequence: 6
  givenname: M. V.
  orcidid: 0000-0002-3628-0804
  surname: Tretyakova
  fullname: Tretyakova, M. V.
  organization: Sechenov University
– sequence: 7
  givenname: V. I.
  orcidid: 0000-0001-5888-0774
  surname: Tsibizova
  fullname: Tsibizova, V. I.
  organization: Almazov National Medical Research Centre, Health Ministry of Russian Federation
– sequence: 8
  givenname: N. D.
  orcidid: 0000-0002-8100-0189
  surname: Degtyareva
  fullname: Degtyareva, N. D.
  organization: Sechenov University
– sequence: 9
  givenname: A. V.
  orcidid: 0000-0003-2917-9318
  surname: Mulenkova
  fullname: Mulenkova, A. V.
  organization: Sechenov University
– sequence: 10
  givenname: J.-C.
  orcidid: 0000-0002-9899-9910
  surname: Gris
  fullname: Gris, J.-C.
  organization: Sechenov University; University of Montpellier
– sequence: 11
  givenname: M. V.
  orcidid: 0000-0001-5249-707X
  surname: Kvaratskheliia
  fullname: Kvaratskheliia, M. V.
  organization: Sechenov University
– sequence: 12
  givenname: E.
  orcidid: 0000-0002-8980-9783
  surname: Grandone
  fullname: Grandone, E.
  organization: Sechenov University; Research Center «Casa Sollievo della Sofferenza»
– sequence: 13
  givenname: F. E.
  orcidid: 0000-0002-8882-1588
  surname: Yakubova
  fullname: Yakubova, F. E.
  organization: Sechenov University
– sequence: 14
  givenname: D. V.
  orcidid: 0000-0002-3367-9844
  surname: Blinov
  fullname: Blinov, D. V.
  organization: Sechenov University; Institute for Preventive and Social Medicine; Moscow Haass Medical – Social Institute
– sequence: 15
  givenname: A. D.
  orcidid: 0000-0001-7415-4633
  surname: Makatsariya
  fullname: Makatsariya, A. D.
  organization: Sechenov University
BookMark eNo9kU1PGzEQhq0KpKaB_-ATt934cze-IEVpoUhBHAriaPljvDIKdmSv2vLv64TCaV69M_NqNM83dJZyAoSuKOnpOAq1YpzybuRiXGXbT2-pL3DoGWG8F0R-QQsmCek4VeKs6Y_Zr-iy1hdCCFO0teQC2e0-pujMHtc4pRiaTA5wDnjzfXP_-KujfPX7-Qabv7HimPChwJRMmvGf_AoJmxn7GAIUaNZc4ivUGUo97k9NmjnmdIHOg9lXuPxfl-jp5sfj9me3e7i92252nWN8LTsv25XDaIwPwYW155KDctIO1jjuZRDeMCGVEtQCt9YLEFYqAnzw0jabL9Hde67P5kUf2jGmvOlsoj4ZuUzalDm6PehB-rUMTjkflFAmGCmcZ56LAdZ0YKxlXb9nuZJrLRA-8yjRJwD6-FR9fKrOVjcAugHQRwC6AeD_ADxKf4U
CitedBy_id crossref_primary_10_17749_2313_7347_ob_gyn_rep_2023_460
Cites_doi 10.1111/j.1538-7836.2006.02205.x
10.1182/blood.V87.10.4235.bloodjournal87104235
10.1371/journal.pone.0112935
10.1111/1471-0528.16552
10.1055/s-0041-1727282
10.1160/TH08-05-0330
10.1111/jth.15445
10.1161/ATVBAHA.111.223610
10.1182/blood.V87.10.4223.bloodjournal87104223
10.1182/blood-2012-07-442285
10.1186/s12884-022-04405-8
10.1016/S0049-3848(19)30359-7
10.1101/2020.08.23.20177824
10.1056/NEJM198212023072306
10.14740/jh347w
10.1159/000214853
10.2147/IBPC.S50641
10.1160/TH03-11-0683
10.1182/blood-2014-06-528406
10.1182/blood-2012-01-405134
ContentType Journal Article
DBID AAYXX
CITATION
DOA
DOI 10.17749/2313-7347/ob.gyn.rep.2023.405
DatabaseName CrossRef
Directory of Open Access Journals
DatabaseTitle CrossRef
DatabaseTitleList
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
EISSN 2500-3194
EndPage 230
ExternalDocumentID oai_doaj_org_article_65d85fc9cdf949afa54cd2d346e81622
10_17749_2313_7347_ob_gyn_rep_2023_405
GroupedDBID AAYXX
ALMA_UNASSIGNED_HOLDINGS
CITATION
GROUPED_DOAJ
ID FETCH-LOGICAL-c2385-d531367aadffcf8d353e9c5b6bac3d5f4da2459941be3bbd4e4b590e36d5b9943
IEDL.DBID DOA
ISSN 2313-7347
IngestDate Mon Oct 21 19:39:11 EDT 2024
Thu Nov 21 22:37:57 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2385-d531367aadffcf8d353e9c5b6bac3d5f4da2459941be3bbd4e4b590e36d5b9943
ORCID 0000-0001-8404-1042
0000-0002-3367-9844
0000-0002-9899-9910
0000-0002-8882-1588
0000-0001-5888-0774
0000-0001-5249-707X
0000-0002-1339-4155
0000-0003-0764-4477
0000-0002-3628-0804
0000-0002-0725-9686
0000-0002-8100-0189
0000-0001-7415-4633
0000-0003-2917-9318
0000-0002-8980-9783
0000-0002-7756-8935
OpenAccessLink https://doaj.org/article/65d85fc9cdf949afa54cd2d346e81622
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_65d85fc9cdf949afa54cd2d346e81622
crossref_primary_10_17749_2313_7347_ob_gyn_rep_2023_405
PublicationCentury 2000
PublicationDate 2023-05-22
PublicationDateYYYYMMDD 2023-05-22
PublicationDate_xml – month: 05
  year: 2023
  text: 2023-05-22
  day: 22
PublicationDecade 2020
PublicationTitle Акушерство, гинекология и репродукция
PublicationYear 2023
Publisher IRBIS LLC
Publisher_xml – name: IRBIS LLC
References ref13
ref12
ref15
ref14
ref20
ref11
ref10
ref2
ref1
ref17
ref16
ref19
ref18
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – ident: ref13
  doi: 10.1111/j.1538-7836.2006.02205.x
– ident: ref2
  doi: 10.1182/blood.V87.10.4235.bloodjournal87104235
– ident: ref10
  doi: 10.1371/journal.pone.0112935
– ident: ref11
  doi: 10.1111/1471-0528.16552
– ident: ref19
  doi: 10.1055/s-0041-1727282
– ident: ref17
  doi: 10.1160/TH08-05-0330
– ident: ref18
  doi: 10.1111/jth.15445
– ident: ref14
  doi: 10.1161/ATVBAHA.111.223610
– ident: ref3
  doi: 10.1182/blood.V87.10.4223.bloodjournal87104223
– ident: ref6
  doi: 10.1182/blood-2012-07-442285
– ident: ref7
  doi: 10.1186/s12884-022-04405-8
– ident: ref9
  doi: 10.1016/S0049-3848(19)30359-7
– ident: ref20
  doi: 10.1101/2020.08.23.20177824
– ident: ref1
  doi: 10.1056/NEJM198212023072306
– ident: ref15
  doi: 10.14740/jh347w
– ident: ref12
  doi: 10.1159/000214853
– ident: ref8
  doi: 10.2147/IBPC.S50641
– ident: ref16
  doi: 10.1160/TH03-11-0683
– ident: ref5
  doi: 10.1182/blood-2014-06-528406
– ident: ref4
  doi: 10.1182/blood-2012-01-405134
SSID ssj0002911945
Score 2.272074
Snippet Introduction. The pandemic of a novel coronavirus infection has demonstrated the importance of assessing the ADAMTS-13/vWF axis in patients with COVID-19,...
Introduction. The pandemic of a novel coronavirus infection has demonstrated the importance of assessing the ADAMTS-13/vWF axis in patients with COVID-19,...
SourceID doaj
crossref
SourceType Open Website
Aggregation Database
StartPage 221
SubjectTerms adamts-13 metalloproteinase
gestation
pregnancy
von willebrand factor
vwf
Title Clinical significance of ADAMTS-13/vWF axis in pregnant women at different trimesters of gestation
URI https://doaj.org/article/65d85fc9cdf949afa54cd2d346e81622
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrZ3LSwMxEMaD9iBeRFHxTQ7iLX3ktZtjtS296KUVvYU8RZBW-hD9753ZbUtvXrwGsoTfbJJvyPANIbegOBTkNyUDacCZNEkwkBGCcc91cLGIqXqKGY6Kp9ey10ebnE2rL6wJq-2Ba3AtrWKpcjAhZiONy07JEHkUUqeyo3l9-rb1VjKFZzCHPWyqDsWgXwQrhCz2yB2eECB3TGsz2Jr65tvPpDlL6F3JRVNiH7utG2rLyL-6cQaH5GAlFWm3XuIR2Zktj4lfGXl-UKy8wDofDBudZtrtdR_HI9YRra-XAXXf73P6PqGfs_SGtS60slqgbkHXLVEWdIHW_miUMMf5-NBUhemEPA_644chW_VJYAEoKxZhHwldOBdzDrmMQolkgvLauyCiyjI6LpUxsuOT8D7KJL0y7SR0VB6GxSlpTKaTdEaoMdmBRBHSmSy9Dh4Yx7ItuGtHAwnnOSnWbOxnbYdhMY1AqhapWqRqp94CVQtULVK1QPWc3CPKzSy0ta4GINh2FWz7V7Av_uMjl2QfF4UlAJxfkcZitkzXZHcelzfVT_QL5MrInw
link.rule.ids 315,782,786,866,2106,27933,27934
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+significance+of+ADAMTS-13%2FvWF+axis+in+pregnant+women+at+different+trimesters+of+gestation&rft.jtitle=%D0%90%D0%BA%D1%83%D1%88%D0%B5%D1%80%D1%81%D1%82%D0%B2%D0%BE%2C+%D0%B3%D0%B8%D0%BD%D0%B5%D0%BA%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F+%D0%B8+%D1%80%D0%B5%D0%BF%D1%80%D0%BE%D0%B4%D1%83%D0%BA%D1%86%D0%B8%D1%8F&rft.au=K.+N.+Grigoreva&rft.au=N.+R.+Gashimova&rft.au=V.+O.+Bitsadze&rft.au=L.+L.+Pankratyeva&rft.date=2023-05-22&rft.pub=IRBIS+LLC&rft.issn=2313-7347&rft.eissn=2500-3194&rft.volume=17&rft.issue=2&rft.spage=221&rft.epage=230&rft_id=info:doi/10.17749%2F2313-7347%2Fob.gyn.rep.2023.405&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_65d85fc9cdf949afa54cd2d346e81622
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2313-7347&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2313-7347&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2313-7347&client=summon